Sharemaestro company-news research for Teva Pharmaceutical Industries Limited (TEVAN), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
MEX
Mexico
Measured evidence
Company news sentiment
TEVAN news sentiment
Teva Pharmaceutical Industries Limited
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone50Neutral is 50
Balanced news tone
36/100 evidence confidence
100% direct company focus
1 current stories across 1 publishers
Current company news
Balanced read
Balanced news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.
Latest source headline Teva Pharmaceutical Industries (TEVA) Lifts Outlook On Earnings As Valuation Debate Stays Open simplywall.st · 07 Aug 2026 15:45What supports the read
1 current stories are mapped specifically to TEVAN.
What tempers the read
Only 1 publisher currently contribute to the measured read.
50/100
Weighted toneBalanced news tone
36/100
Evidence confidencethin evidence
100%/100
Company focus1 direct stories
N/A/100
Evidence agreementrequires at least 2 stories
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth12
1.0 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness36
recency-weighted evidenceAgreement0
requires at least 2 storiesSource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
News tone and price action are not far from neutral.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
News subjects
What is shaping the score
Earnings501 stories · 100%
Source mix
Where the evidence comes from
simplywall.st501 stories · 100%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#150Tone
simplywall.stDirect company coverage
Teva Pharmaceutical Industries (TEVA) Lifts Outlook On Earnings As Valuation Debate Stays Open
- Published
- 07 Aug 2026 15:45
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Earlier company news
TEVAN news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
Aug
06
2026
Barchart.comArchivedPositive tone
Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14
- Published
- 6 Aug 2026 15:16
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
31
2026
TipRanksArchivedNeutral tone
Teva Pharmaceutical Industries Limited (TEVAN) Q2 2023 Earnings Report - Results, Call & Slides
- Published
- 31 Jul 2026 22:37
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
25
2026
TipRanksArchivedNeutral tone
Teva Pharmaceutical Industries Limited (TEVAN) Q1 2024 Earnings Report - Results, Call & Slides
- Published
- 25 Jul 2026 12:36
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
24
2026
ReutersArchivedNegative tone
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints
- Published
- 24 Jul 2026 11:03
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
21
2026
TradingViewArchivedNeutral tone
ETFs Investing in Teva Pharmaceutical Industries Limited Sponsored ADR Stocks
- Published
- 21 Jul 2026 19:57
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
12
2026
ReutersArchivedNeutral tone
Teva seeks startups to help solve global pharmaceutical challenges
- Published
- 12 Jul 2026 21:42
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
11
2026
BNN BloombergArchivedNeutral tone
Teva Pharmaceutical Industries Ltd (TEVA:UN): Stock Price, Quote and News
- Published
- 11 Jul 2026 03:48
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
08
2026
Fortune Business InsightsArchivedNegative tone
Active Pharmaceutical Ingredient [API] Market Size, Share, 2034
- Published
- 8 Jul 2026 20:27
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
06
2026
Market Research FutureArchivedNegative tone
Active Pharmaceutical Ingredients (API) Market 2035 | Size, Share Report
- Published
- 6 Jul 2026 17:53
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
01
2026
StocktwitsArchivedNeutral tone
Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment
- Published
- 1 Jul 2026 20:00
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
30
2026
ReutersArchivedNeutral tone
Teva Pharmaceutical Q4 profit gains as branded drugs aid transition from generics
- Published
- 30 Jun 2026 22:49
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
StockInvest.usArchivedPositive tone
Teva Pharmaceutical Industries Stock Price Forecast. Should You Buy TEVA?
- Published
- 28 Jun 2026 04:05
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
Insider MonkeyArchivedNegative tone
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
- Published
- 28 Jun 2026 01:52
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
27
2026
Streetwise ReportsArchivedNeutral tone
Teva Pharmaceutical Advances Neuroscience Pipeline With Strong AUSTEDO Growth & New Acquisition
- Published
- 27 Jun 2026 12:51
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.